The brain of people with pediatric-onset Huntington’s disease show impaired transport of blood sugar, or glucose, and low levels…
Articles by Lindsey Shapiro, PhD
Note: This story was updated Jan. 24, 2024, to correct that Takeda is not supporting WVE-003’s development. Wave Sciences…
In 2023, Huntington’s Disease News brought you the latest in scientific breakthroughs and treatment developments related to Huntington’s…
The contents of Ingrezza (valbenazine) can be taken from their capsules and crushed before being sprinkled on soft foods…
Blocking immune system proteins that are part of the body’s complement cascade — which helps the immune system to fight…
A lab-made version of a plant enzyme prevented toxic huntingtin protein clumps — that drive Huntington’s disease from forming…
The benefits of Ingrezza (valbenazine) for people with Huntington’s disease — reductions in uncontrolled movements and gains in…
Caregivers of people with Huntington’s disease want support programs that will help them in balancing their own care needs…
With early data on AMT-130Â for Huntington’s disease reportedly looking promising, uniQure said it’s planning to meet early…
PTC Therapeutics’ Huntington’s disease treatment candidate PTC518 is well-tolerated and lowers blood levels of the huntingtin protein (HTT) in…